Skip to main content
. 2021 Jun 28;14:11786469211026639. doi: 10.1177/11786469211026639

Table 2.

Tryptophan metabolites in maternal serum, placenta, fetal plasma and brain following pCpG-MuIl17a transfer at E18.5.

3-HK 3-HAA AA
Maternal serum (nM)
 Control 56.7 ± 9.14 70.7 ± 20.2 251.7 ± 24.7
 MIA 72.1 ± 7.42 135.4 ± 23.9 165.0 ± 21.4*
Placenta (fmoL/mg tissue)
 Control 47.1 ± 11.0 19.2 ± 4.14 257.6 ± 29.1
 MIA 36.5 ± 2.57 17.0 ± 0.59 103.9 ± 10.4***
Fetal plasma (nM)
 Control 39.1 ± 3.81 50.8 ± 7.86 309.2 ± 108.5
 MIA 74.2 ± 8.81* 453.3 ± 32.3**** 245.5 ± 37.0
Fetal brain (fmoL/mg tissue)
Subpallium
 Control 117.5 ± 17.8 7.8 ± 0.66 24.7 ± 3.87
 MIA 108.4 ± 7.68 9.4 ± 1.18 29.8 ± 3.21
Pallium
 Control 81.3 ± 10.9 10.3 ± 1.26 19.6 ± 1.99
 MIA 80.0 ± 9.51 10.1 ± 0.93 33.5 ± 5.87

Data are presented as means ± standard error of the mean (SEM).

*

P < .05, ***P < .001, ****P < .0001 vs control.